Method
MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets
- † Equal contributors
1 Departments of Pediatric Oncology and Computational Biology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
2 Division of Pediatric Hematology-Oncology, The Karp Family Research Laboratories, Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA
3 Division of Cell and Molecular Biology, Department of Biology, Boston University, 5 Cummington Street, Boston, MA 02215, USA
4 Harvard Stem Cell Institute and the Howard Hughes Medical Institute, 1 Blackfan Circle, Karp Research Building, Children's Hospital, Boston, MA 02115, USA
Genome Biology 2012, 13:R16 doi:10.1186/gb-2012-13-3-r16
Published: 16 March 2012Additional files
Additional file 2:
Supplementary figures.
Format: PDF Size: 17.2MB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 3:
Supplementary text. Includes text on the use of MAnorm normalized read density to determine whether the peak calling cutoff is comparable between two ChIP-seq data sets; results of downstream analyses following MAnorm are robust to different peak cutoffs; integrating multiple replicates in ChIP-seq data set comparison; derivation of the P-value that quantifies the significance of differential binding at peak regions; using MAnorm to compare H3K36me3 ChIP-seq data; assessing the effect of number of common peaks used in analysis; comparing signal-to-noise ratio before and after normalization; Supplementary Methods.
Format: DOC Size: 55KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 4:
Supplementary Tables - comparison of MAnorm with other methods.
Format: XLS Size: 53KB Download file
This file can be viewed with: Microsoft Excel Viewer
